International Journal of Pediatric Otorhinolaryngology
Antibacterial effect of electrospun polycaprolactone/polyethylene oxide/vancomycin nanofiber mat for prevention of periprosthetic infection and biofilm formation
Introduction
Periprosthetic infections are thought to be caused by invading bacteria at the time of surgery. Treating infected prosthesis is exceedingly difficult, especially due to the inherent difficulties of treating an established biofilm [1]. The incidence of methicillin-resistant Staphylococcus aureus (MRSA) infection after middle ear surgery has recently increased [2]. Once a MRSA biofilm has formed on an implanted medical device such as ossiculoplasty prostheses, implantable hearing devices, and silicone prostheses, it is difficult to disrupt. Biofilm-infected implants must often be removed and replaced, placing the patient at increased risk of complications such as persistent nontractable infection or endocochlear inflammation in cochlear implant users [3], [4]. Current antimicrobial therapies for biofilm have proven largely unsuccessful by conventional systemic antibiotic treatment [5]. Biofilm and chronic inflammation may have a role in prostheses extrusion [6]. By extended release of antibiotic locally, higher effective concentrations may be achieved while avoiding potentially toxic systemic concentrations [7], [8]. Lee et al. reported effective treatment of MRSA otitis media using local delivery of vancomycin combined with pluronic F-127 gel [9]. To date, there are no reports on preventive antibiotic loaded nanofiber mat against middle ear periprosthetic infection or biofilm by MRSA.
Electrospun porous nanofiber scaffolds have been effective in delivering drug or biologically active molecules such as growth factors [8], [9]. Poly(ɛ-caprolactone) (PCL), a semicrystalline biodegradable polyester, belongs to the poly(a-hydroxy acids) family. Its copolymers, lactides and glycolide are getting increasing attention because of their controllable biodegradation rates in the desirable ranges (slower) and also more suitable and tailor-made mechanical properties (more flexible and softer) for some applications such as long-term drug delivery and tissue repair and regeneration [10], [11], [12], [13].
In this study, we developed a biocompatible and biodegradable vancomycin (VM)-eluting electrospun PCL/(PEO/VM)/PCL nanofiber mat. The purpose of this study was to evaluate the efficacy of this nanofiber mat for preventing MRSA biofilm on the prostheses and otitis media.
Section snippets
Fabrication and characterization of nanofiber mat
Poly(ɛ-caprolactone) (PCL, Mn = 70,000–90,000) and poly(ethylene oxide) (PEO, Mw = 900,000) were purchased from Sigma-Aldrich (St. Louis, MO, USA). PCL was prepared at a fixed concentration of 10% (w/w) in an 80:20 mixture of methylene chloride (MC):dimethylformamide (DMF). As a drug, we used vancomycin (VM, Samjin Pharm, Seoul, Korea).
As shown in Fig. 1A, to fabricate sandwiched nanofibrous mats, PCL and PEO/VM solutions were electrospun in a layer-by-layer manner in a 10-ml syringe with a 21 G
Morphology and functionalization of the electrospun nanofiber mat
The surface and cross-sectional optical images of Fig. 1B and C show a fibrous mat consisting of three-layered electrospun fibers, PCL/(PEO/VM)/PCL fibers, with a total thickness of 0.21 mm. In the cross-sectional optical image, the red dye was mixed with the PEO/VM to demonstrate the PEO/VM region in the multi-layered mat and the red color means the PEO/VM region. As shown in the SEM image of Fig. 1D, electrospun PCL nanofibers were used as a porous structured layer for controlling drug
Discussion
The danger of MRSA infections result from not only the emergence of multidrug resistance but also the occurrence of strong biofilm-forming bacteria [15]. Once a bacterial biofilm has formed on an implanted medical device or damaged tissue, it is difficult to disrupt. Conventional systemic delivery of antibiotics often has little effect, because of poor penetration into ischemic and necrotic tissue and can cause systemic toxicity with associated renal and hepatic complications. A general
Conclusion
Results of in vitro release and anti-MRSA experiments suggest that the developed VM containing NF mat are capable of effectively delivering VM in a controlled fashion with prolonged duration. These results indicate that electrospun VM-eluting PCL/(PEO/VM)/PCL NFs are good candidates for prevention of MRSA infection.
Acknowledgement
This study was supported by Fishery Commercialization Technology Development Program, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea (grant no. A120942).
References (22)
- et al.
Endocochlear inflammation in cochlear implant users: case report and literature review
Int. J. Pediatr. Otorhinolaryngol.
(2013) - et al.
Regional delivery of vancomycin using pluronic F-127 to inhibit methicillin resistant Staphylococcus aureus (MRSA) growth in chronic otitis media in vitro and in vivo
J. Controlled Release
(2004) - et al.
Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds
J. Controlled Release
(2004) - et al.
Antibiotic-eluting medical devices for various applications
J. Controlled Release
(2008) - et al.
Limitations in the use of rifampicin–gelatin grafts against virulent organisms
J. Vas. Surg.
(2002) - et al.
Preparation and characterization of electrospun PLGA/gelatin nanofibers as a potential drug delivery system
Colloids Surf., B: Biointerfaces
(2011) - et al.
Electrospun diclofenac sodium loaded Eudragit® L 100-55 nanofibers for colon-targeted drug delivery
Int. J. Pharm.
(2011) - et al.
Electrospun drug-loaded core-sheath PVP/zein nanofibers for biphasic drug release
Int. J. Pharm.
(2012) - et al.
Prevention and control of biofilm-based medical-device-related infections
FEMS Immunol. Med. Microbiol.
(2010) - et al.
Antibacterial coatings on titanium implants
J. Biomed. Mater. Res.
(2009)
Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin
Crit. Care Med.
Cited by (29)
Antibiotics-loaded nanofibers fabricated by electrospinning for the treatment of bone infections
2023, Arabian Journal of ChemistryCitation Excerpt :However, the outcomes have been provided in neither of the studies. Only eight articles mentioned the identification code of the Ethics Committee (Ashbaugh et al., 2016; Bottino et al., 2019; Ho et al., 2020, 2017; Jang et al., 2015; Sutrisno et al., 2018; Xue et al., 2014a; Yu et al., 2020) and 6 mentioned housing conditions (Bottino et al., 2019; Gao et al., 2016; Gilchrist et al., 2013; Jang et al., 2015; Miller et al., 2019; Sutrisno et al., 2018). Three articles did not mention the number of animals used in the experiments (Gilchrist et al., 2013; Sutrisno et al., 2018; Xue et al., 2015).
Biomedical Applications of Electrospun Polymer and Carbon Fibers
2022, Encyclopedia of Materials: Plastics and PolymersNanofibers as drug-delivery systems for antimicrobial peptides
2021, Drug Discovery TodayCitation Excerpt :Furthermore, when the coated vascular prosthetic grafts were inserted into the backs of rabbits, the peptide was detected in the peripheral blood for up to 5 weeks [90]. Jang et al. [91] produced PCL/PEO electrospun nanofibers with vancomycin (10%wt.) by the blending method that were used to prevent infections in hearing aids [91].
Electrospun vancomycin-loaded nanofibers for management of methicillin-resistant Staphylococcus aureus-induced skin infections
2020, International Journal of PharmaceuticsCitation Excerpt :Owing to their unique characteristics, nanofibers can be efficiently applied onto the skin to allow the delivery of high antibiotic concentration to the infected area, and thus reducing adverse reactions associated with systemic administration, minimizing cost and hospitalization period, and improving patient compliance and therapeutic outcomes (Chen et al., 2012; Heunis et al., 2013; Karthikeyan et al., 2015; Schneider et al., 2018). Several types of nanofibers including, poly(D,L)-lactide-co-glycolide nanofibers (Liu et al., 2018; Liu et al., 2015) ALG/PEO/soy protein nanofibers (Wongkanya et al., 2017), collagen/poly(l-lactide) nanofibers (Zhang et al., 2016), gelatin/dopamine nanofibers (Dhand et al., 2016; Dhand et al., 2017), chitosan/PEO nanofibers (Karimi et al., 2019) and poly(ɛ-caprolactone) (PCL)/PEO nanofibers (Jang et al., 2015) have been utilized previously to incorporate vancomycin for various biomedical applications. In the current study, vancomycin-loaded nanofibers were prepared from PEO/ALG blends via electrospinning technique and the physicochemical characteristics of the electrospun fibers have been evaluated.
Cells-on-nanofibers: Effect of polyethyleneimine on hydrophobicity of poly-Ɛ-caprolacton electrospun nanofibers and immobilization of bacteria
2019, Enzyme and Microbial TechnologyCefazolin-loaded polycaprolactone fibers produced via different electrospinning methods: Characterization, drug release and antibacterial effect
2018, European Journal of Pharmaceutical Sciences